Cargando…

Myoinositol vs. Metformin in Women with Polycystic Ovary Syndrome: A Randomized Controlled Clinical Trial

Polycystic ovary syndrome (PCOS) is associated with insulin resistance. Few randomized controlled trials (RCT) compared myoinositol (MI) with metformin (MET) regarding insulin resistance in PCOS. This was an open-label six-month RCT in women with PCOS (n = 45) with interventions MI 4 g/day or MET 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravn, Pernille, Gram, Freja, Andersen, Marianne S., Glintborg, Dorte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786218/ https://www.ncbi.nlm.nih.gov/pubmed/36557221 http://dx.doi.org/10.3390/metabo12121183

Ejemplares similares

Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome
por: Glintborg, Dorte, et al.
Publicado: (2022)

Effect of oral contraceptives and/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2017)

Study on the Effect of Berberine, Myoinositol, and Metformin in Women with Polycystic Ovary Syndrome: A Prospective Randomised Study
por: Mishra, Neha, et al.
Publicado: (2022)

Diabetes Mellitus Mediates Risk of Depression in Danish Women with Polycystic Ovary Syndrome—A National Cohort Study
por: Glintborg, Dorte, et al.
Publicado: (2022)

Cardiovascular disease in a nationwide population of Danish women with polycystic ovary syndrome
por: Glintborg, Dorte, et al.
Publicado: (2018)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
por: Udesen, Pernille Bækgaard, et al.
Publicado: (2020)

Increased risk of thyroid disease in Danish women with polycystic ovary syndrome: a cohort study
por: Glintborg, Dorte, et al.
Publicado: (2019)

Myoinositol Versus Metformin in the Treatment of Polycystic Ovarian Syndrome: A Systematic Review
por: Bodepudi, Ranita, et al.
Publicado: (2023)

Comparison of Clinical, Metabolic and Hormonal Effects of Metformin Versus Combined Therapy of Metformin With Myoinositol Plus D-Chiro-Inositol in Women With Polycystic Ovary Syndrome (PCOS): A Randomized Controlled Trial
por: Bahadur, Anupama, et al.
Publicado: (2021)

Accelerated osteoarthritis in women with polycystic ovary syndrome: a prospective nationwide registry-based cohort study
por: Kluzek, Stefan, et al.
Publicado: (2021)

Genetic Alterations within the DENND1A Gene in Patients with Polycystic Ovary Syndrome (PCOS)
por: Eriksen, Mette B., et al.
Publicado: (2013)

Awareness of polycystic ovary syndrome among obstetrician-gynecologists and endocrinologists in Northern Europe
por: Piltonen, Terhi T., et al.
Publicado: (2019)

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
por: Javed, Zeeshan, et al.
Publicado: (2020)

Abstract 30: A randomized control trial comparing myoinositol based therapy in combination with metformin versus metformin monotherapy on the clinical and hormonal parameters in obese reproductive age women with polycystic ovarian syndrome
por: Nazirudeen, Roshan, et al.
Publicado: (2022)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

Adrenal activity and metabolic risk during randomized escitalopram or placebo treatment in PCOS
por: Glintborg, Dorte, et al.
Publicado: (2018)

Probiotic vs. placebo and metformin: probiotic dietary intervention in polycystic ovary syndrome – A randomized controlled trial
por: Borzan, Valentin, et al.
Publicado: (2023)

Effect of Metformin on Serum Ferritin Level in Women with Polycystic Ovary Syndrome
por: Behradmanesh, S, et al.
Publicado: (2011)

Clinical outcome of various metformin treatments for women with polycystic ovary syndrome
por: Matsuzaki, Toshiya, et al.
Publicado: (2017)

Impaired Prolactin-Lowering Effects of Metformin in Women with Polycystic Ovary Syndrome
por: Krysiak, Robert, et al.
Publicado: (2023)

Differential DNA methylation patterns of polycystic ovarian syndrome in whole blood of Chinese women
por: Li, Shuxia, et al.
Publicado: (2016)

Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
por: Farimani Sanoee, Marzieh, et al.
Publicado: (2011)

Metformin increases pressure pain threshold in lean women with polycystic ovary syndrome
por: Kiałka, Marta, et al.
Publicado: (2016)

Thyroid Status During Pregnancy in Women With Polycystic Ovary Syndrome and the Effect of Metformin
por: Trouva, Anastasia, et al.
Publicado: (2022)

Pioglitazone Enhances Mitochondrial Biogenesis and Ribosomal Protein Biosynthesis in Skeletal Muscle in Polycystic Ovary Syndrome
por: Skov, Vibe, et al.
Publicado: (2008)

The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Guan, Yuanyuan, et al.
Publicado: (2020)

A retrospective survey of quality of reporting on randomized controlled trials of metformin for polycystic ovary syndrome
por: Chen, Baoying, et al.
Publicado: (2014)

Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome
por: Tan, Bee K., et al.
Publicado: (2010)

Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women With Polycystic Ovary Syndrome
por: Riahinejad, Soheila, et al.
Publicado: (2015)

Effects of metformin on pregnancy outcomes in women with polycystic ovary syndrome: A meta-analysis
por: Zeng, Xian-Ling, et al.
Publicado: (2016)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
por: Kumar, Pratap, et al.
Publicado: (2012)

Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
por: Attia, Ghalia M, et al.
Publicado: (2023)

Myoinositol in Autoimmune Thyroiditis
por: Paparo, Sabrina Rosaria, et al.
Publicado: (2022)

SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial
por: Garcia-Beltran, Cristina, et al.
Publicado: (2023)

Metformin improved health-related quality of life in ethnic Chinese women with polycystic ovary syndrome
por: Huang-TzOu, et al.
Publicado: (2016)

Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome
por: Al-Ruthia, Yazed Sulaiman, et al.
Publicado: (2017)

Association between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
por: Chang, Hui Hua, et al.
Publicado: (2019)

Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program
por: AlHussain, Fatimah, et al.
Publicado: (2020)

Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic ovary syndrome women
por: Pradas, Irene, et al.
Publicado: (2019)

Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome
por: Ma, Rui-Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ud09sd0v0pjp88aiu363v0f5fo